Condition: HIV-1-infection · Sponsor: Euresist Network GEIE
Cohort based prospective monitoring of the spread of HIV drug resistance during a phase when new anti-HIV drugs are introduced.
This description comes directly from the study's public registry record.
FRANCESCA INCARDONA · +393356112830 · francesca.incardona@euresist.org
dario corsini · +39 3483381097 · dario.corsini@euresist.org
Always discuss trial participation with your own doctor first.
| University Hospital of Cologne | Cologne, Germany | Recruiting |
| University Hospital of Siena | Siena, Italy | Recruiting |
| Pomeranian Medical University Szczecin | Szczecin, Poland | Recruiting |
| Karolinska Institutet | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06127290